What was the outcome of the PARADIGM-HF trial?
The PARADIGM-HF trial demonstrated an absolute 4.7% reduction in the primary outcome of cardiovascular death or heart failure hospitalization, with a 20% reduction in sudden cardiac death. The number of patients who would need to be treated to prevent 1 primary endpoint over 27 months was 21.